Position Your Brand in Front of Obesity Drug Development's Key Decision-Makers
As the obesity therapeutics landscape rapidly evolves beyond first-generation GLP-1s, drug developers are under increasing pressure to differentiate their pipelines, improve patient outcomes, and demonstrate long-term adherence. From enhancing tolerability and preserving muscle mass to advancing novel mechanisms, combination strategies, precision medicine approaches, and delivery innovations, biopharma teams are actively seeking partners that can help accelerate development and overcome critical scientific challenges.
The 3rd Obesity & Weight Loss Drug Development Summit West brings together a highly targeted audience of pharma and biotech leaders spanning discovery, preclinical, translational and clinical development. Through strategic discussions and focused networking, attendees will benchmark their development strategies, evaluate emerging opportunities, and identify the technologies, services, and partnerships needed to remain competitive in this fast-moving market.
For solution providers, this is a unique opportunity to showcase your expertise, build relationships with key decision-makers, and position your solutions at the centre of the next wave of obesity innovation.
What to Expect?
Meet New Clients
Expand your client base within the metabolic community by networking face-to-face with dedicated attendees actively seeking solutions to overcome their drug development challenges.
Demonstrate Your Expertise
Present your work, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Interest Areas
Partner with this industry-focus obesity meeting to empower and support drug developers in their quest to advance novel obesity therapies to the clinic, get in touch if you have expertise in:
- De-Risking Development with Strategic Preclinical CRO Expertise
- Unlocking Actionable Insights with Next-Generation Biomarkers
- Accelerating Clinical Execution with End-to-End CRO Support
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Edward O'Keefe
Partnerships Manager
3rd Obesity & Weight Loss Drug Development Summit West